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Protocol
========

1. Preparing anti-PECAM-1 antibody-conjugated magnetic beads (Dynabeads)
------------------------------------------------------------------------

1.  Prepare 0.1% BSA in PBS by mixing 50 mg BSA in 50 ml PBS using a vortex until BSA dissolves. Sterilize by filtering through 0.22 μm syringe filter. Store at 4°C.

2.  In the TC hood, transfer 200 μl of well resuspended sheep anti-rat IgG Dynabeads into a 1.5 ml Eppendorf tube and wash the beads: Mount tube on MPC and let sit for about 1 min to allow the beads to sediment. Aspirate supernatant, remove the tube from MPC and resuspend the beads in 1 ml of sterile 0.1% BSA/PBS. Pipette up and down to resuspend beads.

3.  Repeat wash three more times, for a total of four washes.

4.  Remove tube from MPC and resuspend the beads in 500 μl of 0.1% BSA/PBS.

5.  Add 10 μl rat anti-mouse PECAM-1 (CD-31) antibody to the tube.

6.  Tumble overnight at 4°C in the cold room or 2 hrs at room temperature.

7.  Wash the beads with sterile 0.1% BSA/PBS as described in step 1.2 four times.

8.  Remove tube from MPC and resuspend the beads in 200 μl 0.1% BSA/PBS. Store anti-PECAM-1 antibody-conjugated Dynabeads at 4°C for up to 1 month.

2. Isolating mouse pulmonary endothelial cells from neonatal mice
-----------------------------------------------------------------

Prior to proceeding with the tissue purification protocol, IACUC Committee approval of the procedure is required.

1.  Prepare the following: 15 ml of 1 mg/ml C/D solution in DMEM. Filter with 0.22 μm syringe filter and warm to 37°C.50 ml conical tube with 15 ml DMEM, store on iceIsolation Media (IM) containing 20% FBS and 1x penicillin/streptomycin in DMEM2% gelatin. Mix 2 g of bovine skin gelatin with 100 ml dd water, autoclave 15 minutes and store at 4°C. Warm to 37°C to liquefy before coating TC flasks.

2.  Anesthetize three 6-8 day old pups using an IP injection of Ketamine (100 mg/kg) and xylazine (10 mg/kg). Check for effectiveness of anesthesia and dissect animals one by one, as follows: Pin pups to board, soak skin with 70% Ethanol and remove skin from the chest area with sterile dissection scissors. Excise the rib cage to expose lungs.

3.  Aseptically excise individual lung lobes, being careful not to dissect the bronchi and any visible connective tissue around the lungs. Combine all lungs in ice-cold DMEM. Euthanize the pups.

4.  Working in the TC hood, remove lung lobes from DMEM, place in a 100 mm TC dish and aspirate excess DMEM.

5.  Using sterile scissors, mince the tissue finely by cutting \~100 times. Transfer to 15 ml warm C/D solution for enzymatic digestion. Incubate 45 minutes at 37°C on a rotator.

6.  In the TC hood, aspirate the digested tissue suspension into to a 20 ml syringe with 14 g cannula attached and triturate clumps into a single cell suspension, at least 12 times.

7.  Pass the tissue suspension through a 70 μm cell strainer and wash the strainer with 15 ml IM to stop digestion.

8.  Pellet cell suspension by centrifugation at 400x g for 5 minutes.

9.  Aspirate supernatant and resuspend pellet in 3 ml 0.1% BSA/PBS.

10. Transfer cell suspension to 5 ml round-bottom polystyrene tube and add 22.5 μl anti-PECAM-1 antibody-conjugated Dynabeads. Tumble at room temperature for 12 minutes.

11. Coat a T75 flask with 2 mL 2% gelatin and aspirate excess gelatin. Allow gelatin to dry inside the TC hood for about 30 minutes prior to plating cells.

12. After bead incubation is complete (step 2.10), split cell suspension equally into three Eppendorf tubes and mount on the MPC.

13. When the beads have sedimented using the MPC (\~1 min), collect supernatant, remove tube from MPC, wash beads with \~1 ml 0.1% BSA/PBS, and then remount on the MPC.

14. Repeat wash four times (total 5 washes)

15. Resuspend beads in 1 ml of VascuLife with EnGS-Mv Life Factors Kit and 1x penicillin/streptomycin (VL) per tube, mixing well.

16. Plate on a pre-coated T75 flask and bring total volume in each flask to 10 ml with VL.

17. Change media the following day, allow 1 full day of growth, and then change half of the media every other day. When cells are \>70-80% confluent or more (usually after 3-4 days of culture), they can be sorted with anti-ICAM-2 Dynabeads.

3. Preparing anti-ICAM-2 antibody-conjugated Dynabeads
------------------------------------------------------

1.  Anti-ICAM-2 antibody-conjugated Dynabeads are used to further purify cells that have been selected with anti-PECAM-1 antibody- conjugated Dynabeads and cultured until confluent. This procedure is performed as described for anti-PECAM-1 antibody-conjugated Dynabeads (1, above), except that anti-mouse ICAM-2 (CD-102) antibody is used instead of anti-PECAM-1 antibody.

2.  Anti-ICAM-2 antibody-conjugated Dynabeads can be stored at 4°C for up to 1 month.

4. Sorting Mouse Lung Endothelial Cells with anti-ICAM-2 Dynabeads
------------------------------------------------------------------

1.  Coat T75 tissue culture flask with 2% gelatin.

2.  Aspirate the media from the confluent T75 flask with cells and wash with 8 ml PBS.

3.  Aspirate PBS, add 2 ml 0.05% Trypsin/EDTA and let cells detach (about 5 minutes). Tap flasks lightly to aid detaching.

4.  When cells have detached, add 2 ml IM to inhibit trypsin and scrape cells to detach any remaining adherent cells. Transfer cell suspension to a 15 ml tube and spin down for 5 min at 400x g.

5.  Aspirate the media and resuspend cell pellet in 2 ml 0.1%BSA/PBS.

6.  Transfer to a 5 ml polystyrene round-bottom tube and add 10 μl anti-ICAM-2 Dynabeads. Tumble for 12 minutes at RT.

7.  Split cell suspension into two 1.5 ml Eppendorf tubes and mount on MPC.

8.  Aspirate supernatant after beads have adhered for one minute. Remove tubes from MPC and resuspend each tube in 1 ml 0.1% BSA/PBS. Remount on MPC.

9.  Repeat wash four times (total of 5 washes).

10. Resuspend each tube with 1 ml VL and perform a cell count.

11. Plate cells at 250-350K cells per T25 flask and/or 750K-1 million cells per T75 flask.

12. Bring volume to 5 ml VL in T25 flasks, and 10 ml in T75 flasks.

13. Change media every other day. Cells can be used for experiments when culture reaches about 80% confluency, usually in 2-3 days.

5. Representative Results
-------------------------

Typically, after 6-7 days from the initial preparation of the cells, we are able to obtain about 1.2 - 1.5 x 10^6^ pulmonary endothelial cells from three 6-8 day old pups. Cells display typical \"cobblestone\" morphology under light microscopy and show VE-cadherin (CD144) staining at cell-cell junctions, which is characteristic for endothelial cells (Figure 1). Majority of MLECs express VE-cadherin and VEGFR2 as demonstrated by FACS analysis (Figure 2). Usually, we use them for experiments within two weeks after the initial MLEC isolation.

**Figure 1.** Microscopic analysis of confluent MLEC monolayer. (A) Light microscopy image shows cobblestone morphology of cultured cells typical for endothelial cells. Uniform round structures located in the perinuclear area of many cells are the magnetic beads used for MLEC isolation. (B) Endothelial-specific VE-cadherin is localized at the cell-cell junctions as shown using confocal microscopy. Bar is representative of 20μm.

**Figure 2.** FACS analysis of cultured MLECs labeled with antibodies specific for endothelial-specific markers: VE-cadherin (CD144) or VEGFR2, as indicted, followed by phycoerythrin-conjugated secondary antibody, confirms endothelial identity of isolated MLECs. Red line indicates isotype-specific control, green line indicates anti -VE-cadherin or anti-VEGFR2 - specific-IgG.

Discussion
==========

Microvascular ECs have proven to be a useful model in many areas of vascular biology and are believed to be more physiologically relevant to study (e.g. angiogenesis) than widely studied HUVECs ^3^. Previously, it has been reported that microvascular ECs can be obtained from kidney, heart, skin, retina, brain, gliomas, adipose tissue and also lung ^2,\ 4-7,\ 10,\ 11^. However, a consistent and reliable method for isolation of microvascular ECs is still required. The procedure presented here is a modification of a previously published protocol ^2^; it differs from most published procedures in that it uses pups instead of adult animals. This is crucial for the isolation success as cells from young animals have a higher proliferation potential and cultures derived from their tissues tend to yield higher number of cells. One week old animals seem to be optimal, but younger mice (4 day-old) can also be used. Also, higher or lower numbers of pups can be used if required, as we have been successful in isolating MLECs from one pup. However, while scaling up or down the isolation process, cell plating density must remain unchanged, as this is also critical for cell proliferation. The 2-step purification process of MLECs using magnetic beads conjugated first to anti-PECAM-1 and than anti-ICAM-2 antibodies is much more efficient at obtaining pure EC cultures than the previously described single-step purification procedures. This protocol eliminates the need to use very laborious manual techniques, gradient centrifugation and less efficient FACS sorting for discarding contaminating cells such as fibroblasts, blood cells and smooth muscle cells. The resulting MLEC population can be used for *in vitro* analysis of angiogenic responses, vascular permeability and leukocyte transmigration, wound healing as well as biochemical analysis of signaling pathways. If required, MLECs can be plated on different surfaces such as fibronectin or gelatin-coated coverslips for immunofluorescence or electrode arrays for trans-endothelial resistance (TER) measurements. Obtained results can be directly compared to the phenotypes observed *in vivo*, which is especially important in the context of the growing number of knockout and transgenic mouse lines. Successful implementation of this method for *in vitro* analysis of cellular mechanisms underlying defects observed *in vivo*, has already been presented ^12^.
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